
Jazz Pharmaceuticals plc JAZZ
$ 167.53
-1.11%
Quarterly report 2025-Q3
added 11-05-2025
Jazz Pharmaceuticals plc DPO Ratio 2011-2026 | JAZZ
Annual DPO Ratio Jazz Pharmaceuticals plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 136 | 122 | 80.8 | 77.6 | 77.6 | 78 | 75.1 | 74 | 134 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 136 | 74 | 95 |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.71 | 1.88 % | $ 17 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
28.5 | $ 25.87 | -0.79 % | $ 1.25 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Brickell Biotech
BBI
|
105 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Baudax Bio
BXRX
|
140 | - | 0.59 % | $ 63 K | ||
|
CASI Pharmaceuticals
CASI
|
123 | $ 0.95 | -0.72 % | $ 129 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Celldex Therapeutics
CLDX
|
6.17 K | $ 25.15 | -1.95 % | $ 1.62 M | ||
|
AIkido Pharma
AIKI
|
32.8 K | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Catalyst Biosciences
CBIO
|
18.8 | $ 14.01 | 3.7 % | $ 922 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Biogen
BIIB
|
65.4 | $ 164.87 | 0.27 % | $ 24 B | ||
|
Avid Bioservices
CDMO
|
62.3 | - | - | $ 789 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
83.2 | $ 23.32 | 2.71 % | $ 2.76 B |